FDA Inspection 1323692 — Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. — FEI 2243471

The FDA completed an inspection of Roche Molecular Systems, Inc. on Jun 12, 2026 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 12, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Branchburg, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.